Okla. Stat. tit. 36, § 36-6964
This is the official text of Okla. Stat. tit. 36, § 36-6964, part of Oklahoma’s Stat. tit. 36, — part of the compiled statutory law of Oklahoma, published by the state as "Stat. tit. 36,." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Formulary to identify drugs that offer greatest value
Official statutory text
A. A health insurer's pharmacy and therapeutics committee (P&T
committee) shall establish a formulary, which shall be a list of
prescription drugs, both generic and brand name, used by
Oklahoma Statutes - Title 36. Insurance Page 1438
practitioners to identify drugs that offer the greatest overall
value.
B. A health insurer shall prohibit conflicts of interest for
members of the P&T committee.
1. A person may not serve on a P&T committee if the person is
currently employed or was employed within the preceding year by a
pharmaceutical manufacturer, developer, labeler, wholesaler or
distributor.
2. A health insurer shall require any member of the P&T
committee to disclose any compensation or funding from a
pharmaceutical manufacturer, developer, labeler, wholesaler or
distributor. Such P&T committee member shall be recused from voting
on any product manufactured or sold by such pharmaceutical
manufacturer, developer, labeler, wholesaler or distributor.
committee) shall establish a formulary, which shall be a list of
prescription drugs, both generic and brand name, used by
Oklahoma Statutes - Title 36. Insurance Page 1438
practitioners to identify drugs that offer the greatest overall
value.
B. A health insurer shall prohibit conflicts of interest for
members of the P&T committee.
1. A person may not serve on a P&T committee if the person is
currently employed or was employed within the preceding year by a
pharmaceutical manufacturer, developer, labeler, wholesaler or
distributor.
2. A health insurer shall require any member of the P&T
committee to disclose any compensation or funding from a
pharmaceutical manufacturer, developer, labeler, wholesaler or
distributor. Such P&T committee member shall be recused from voting
on any product manufactured or sold by such pharmaceutical
manufacturer, developer, labeler, wholesaler or distributor.
Status: in_force · Read it on the official government site
Need a lawyer in Oklahoma?
Find a Oklahoma lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.